Del Rosario JMM, da Costa KAS, Asbach B, Ferrara F. Exploiting Pan Influenza A and Pan Influenza B Pseudotype Libraries for Efficient Vaccine Antigen Selection. Vaccines (Basel). 2021 Jul 5;9(7):741
We developed an influenza hemagglutinin (HA) pseudotype library encompassing Influenza A subtypes HA1-18 and Influenza B subtypes (both lineages) to be employed in influenza pseudotype microneutralization (pMN) assays. The pMN is highly sensitive and specific for detecting virus-specific neutralizing antibodies against influenza viruses and can be used to assess antibody functionality in vitro. Here we show the production of these viral HA pseudotypes and their employment as substitutes for wildtype viruses in influenza neutralization assays. We demonstrate their utility in detecting serum responses to vaccination with the ability to evaluate cross-subtype neutralizing responses elicited by specific vaccinating antigens. Our findings may inform further preclinical studies involving immunization dosing regimens in mice and may help in the creation and selection of better antigens for vaccine design. These HA pseudotypes can be harnessed to meet strategic objectives that contribute to the strengthening of global influenza surveillance, expansion of seasonal influenza prevention and control policies, and strengthening pandemic preparedness and response.
See Also:
Latest articles in those days:
- Risk of infection of dairy cattle in the EU with highly pathogenic avian influenza virus affecting dairy cows in the United States of America (H5N1, Eurasian lineage goose/Guangdong clade 2.3.4.4b. ge 20 hours ago
- Avian influenza overview September - November 2025 20 hours ago
- [preprint]Airway organoids reveal patterns of Influenza A tropism and adaptation in wildlife species 20 hours ago
- Cats are more susceptible to the prevalent H3 subtype influenza viruses than dogs 23 hours ago
- Overview of high pathogenicity avian influenza H5N1 clade 2.3.4.4b in wildlife from Central and South America, October 2022-September 2025 23 hours ago
[Go Top] [Close Window]


